Medication Adherence

Resource Center

Slideshows

Research Summaries

ACC.25 Conference Coverage

ACC.25 Conference Coverage

High Rates of Semaglutide Discontinuation Among Older Adults with Diabetes in the US and Japan

04/10/2025

Kate Young

A new study reveals high discontinuation rates of semaglutide among older adults with diabetes in the US and Japan, potentially limiting its cardioprotective benefits.

04/10/2025

Research Summary

Research Summary

Can Remotely Delivered Interventions Increase Viral Suppression and Improve Quality of Life for Rural Adults Over 50 Living With HIV?

03/28/2025

Miranda Manier, BA

Researchers tested the impact of four different remotely delivered interventions and observed promising effects on several key health outcomes in patients over the age of 50 living with HIV.

03/28/2025

research summary

research summary

Treatment Modification Is Common Among Patients With T2D for Second-Line Medications

06/18/2024

Leigh Precopio

In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.

06/18/2024

FDA Alert

FDA Alert

FDA Approves First Treatment for Adults With MASH, Serious Liver Disease

03/21/2024

Anthony Calabro, MA

The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.

03/21/2024

FDA ALERT

FDA ALERT

FDA Approves Nedosiran for Patients 9 Years of Age and Older With Primary Hyperoxaluria Type 1

01/29/2024

Anthony Calabro, MA

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

01/29/2024

April 2026

Current Issue

April 2026